InterventionsHuman trial11,361 participants6 monthsCohort study

Combined Semaglutide and Sodium-Glucose Cotransporter-2 Inhibitor Use and Metabolic Outcomes in Chinese Adults With Diabetes: Post Hoc Analysis

Figure 1 from Diabetes Therapy
Open the figure at full size
Figure 1Wang et al.

Diabetes Therapy

The paper

Tianjin Medical University Chu Hsien-I Memorial Hospital & Institute of Endocrinology · Novo Nordisk (China)

Diabetes Therapy · 28 Sep 2026

doi.org/10.1007/s13300-026-01915-yPubMed 42803912

More on GLP-1 and incretin signalling